Rebetol: effectiveness, side effects, alternatives
Summary:
Rebetol: ribavirin
We study 25,907 Rebetol users. The information eHealthMe analyzes includes:
- Effectiveness of Rebetol- Alternative drugs to Rebetol
- 5,134 Rebetol side effects and drug interactions
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
Number of reports submitted per year:

Common Rebetol side effects:
- Fatigue (2,064 reports)
- Rashes (1,812 reports)
- Thrombocytopenia (1,709 reports)
- Fever (1,629 reports)
- Weakness (1,422 reports)
- Depression (1,377 reports)
Rebetol side effects by duration, gender and age:
- Rebetol side effects (25,897 reports)
Browse all side effects of Rebetol:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Rebetol interactions:
- Rebetol and Peg-intron (5,867 reports)
- Rebetol and Pegintron (5,344 reports)
- Rebetol and Intron a (3,623 reports)
- Rebetol and Victrelis (2,691 reports)
- Rebetol and Pegasys (2,366 reports)
- Rebetol and Peginterferon (1,448 reports)
- Rebetol and Sovaldi (1,101 reports)
- Rebetol and Vx-950 (1,032 reports)
- Rebetol and Allopurinol (485 reports)
- Rebetol and Norvasc (397 reports)
Browse all interactions between Rebetol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zDo you take Rebetol?
- You can start a phase IV clinical trial to monitor Rebetol safety and effectiveness.Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
Related publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all drugs on eHealthMe.
Recent studies on eHealthMe:
- Tracleer and Movement - Uncoordinated - 2 seconds ago
- Caduet and Compression Fracture - 18 seconds ago
- Cephalexin and Docefrez drug interaction - 20 seconds ago
- Copaxone and Dimetapp drug interaction - 25 seconds ago
- Prilosec and Tandem Gait Test Abnormal - 28 seconds ago
- Lyrica and Zofran drug interaction - 29 seconds ago
- Glucovance and Herpes Zoster - 29 seconds ago
- Risedronate Sodium and Vasodilatation - 31 seconds ago
- Cd4 Lymphocytes Decreased and pfizer biontech covid vaccine - 38 seconds ago
- Nexium and Saccadic Eye Movement - 39 seconds ago